Literature DB >> 10419886

Differential effects of human granulocyte colony-stimulating factor (hG-CSF) and thrombopoietin on megakaryopoiesis and platelet function in hG-CSF receptor-transgenic mice.

F C Yang1, K Tsuji, A Oda, Y Ebihara, M J Xu, A Kaneko, S Hanada, T Mitsui, A Kikuchi, A Manabe, S Watanabe, Y Ikeda, T Nakahata.   

Abstract

Granulocyte-colony stimulating factor (G-CSF) has been found to act on the neutrophilic lineage. We recently showed that human G-CSF (hG-CSF) has effects similar to early-acting cytokines such as interleukin-3 (IL-3) in the development of multipotential hematopoietic progenitors in transgenic (Tg) mice expressing receptors (R) for hG-CSF. In the present study, we examined the effects of hG-CSF on more mature hematopoietic cells committed to megakaryocytic lineage in these Tg mice. The administration of hG-CSF to the Tg mice increased the numbers of both platelets in peripheral blood and megakaryocytes in the spleen, indicating that hG-CSF stimulates megakaryopoiesis in the Tg mice in vivo. The stimulatory effect of hG-CSF was also supported by the results of studies in vitro. hG-CSF supported megakaryocyte colony formation in a dose-dependent fashion in clonal cultures of bone marrow cells derived from the Tg mice. Direct effects of hG-CSF on megakaryocytic progenitors in the Tg mice were confirmed by culture of single-cell sorted from bone marrow cells. hG-CSF showed a stronger effect on maturation of megakaryocytes in the Tg mice than that of IL-3 alone, but weaker than that of TPO alone. In addition, hG-CSF induced phosphorylation of STAT3 but not Jak2 or STAT5, while TPO induced phosphorylation of both. In contrast to TPO, hG-CSF did not enhance ADP-induced aggregation. Thus, hG-CSF has a wide variety of functions in megakaryopoiesis of hG-CSFR-Tg mice, as compared with other megakaryopoietic cytokines, but the activity of hG-CSF in megakaryocytes and platelets does not stand up to a comparison with that of TPO. Specific signals may be required for the full maturation and activation of platelets.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419886

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

Review 1.  Molecular control of megakaryopoiesis and thrombopoiesis.

Authors:  Itaru Matsumura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

2.  De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways.

Authors:  Vera Magistroni; Mario Mauri; Deborah D'Aliberti; Caterina Mezzatesta; Ilaria Crespiatico; Miriam Nava; Diletta Fontana; Nitesh Sharma; Wendy Parker; Andreas Schreiber; David Yeung; Alessandra Pirola; Sara Readelli; Luca Massimino; Paul Wang; Praveen Khandelwal; Stefania Citterio; Michela Viltadi; Silvia Bombelli; Roberta Rigolio; Roberto Perego; Jacqueline Boultwood; Alessandro Morotti; Giuseppe Saglio; Dong-Wook Kim; Susan Branford; Carlo Gambacorti-Passerini; Rocco Piazza
Journal:  Haematologica       Date:  2019-02-28       Impact factor: 9.941

3.  Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion.

Authors:  Junko Iwasaki-Arai; Hiromi Iwasaki; Toshihiro Miyamoto; Sumiko Watanabe; Koichi Akashi
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.